Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

I am a 67-year-old male with generally good vision. I have had a few floaters in my eyes over the years, but they have generally been small ...

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Most people regain some of the weight they lost after stopping semaglutide. However, physical activity and a balanced diet may help you keep some weight off. Share on Pinterest LeoPatrizi/Getty ...

Announcing a new article publication for Zoonoses journal. This study was aimed at exploring pulmonary tuberculosis (PTB) epidemiological characteristics and trends in China from 2016 to 2022 ...

Nearly 2,000 Londoners were diagnosed with TB last year, making it the UK region with the highest number of diagnoses. These stats come amid soaring cases of this Dickensian superbug that killed an ...

Glucagon-like peptide 1 receptor agonist-based (GLP-1 RA) medications, including semaglutide and the dual GLP-1 RA/gastric inhibitory polypeptide (GIP) medication tirzepatide, have gained ...

Hundreds of people in New Jersey, Delaware, and Pennsylvania are sickened with TB every year, but a recent deadly outbreak in Kansas has some worried about the disease’s spread. Tuberculosis ...

Let's take a closer look at each of these medications. Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient ...